novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Oral anticoagulation – why do we need new drugs

16 Junho 2014

Carlos Aguiar

{edocs}http://www.challengesincardiology.com/images/stories/uploads/Carlos Aguiar.pdf,650,441{/edocs}

Faça aqui o download!

Termos e Condições de Acesso e Utilização

30 Maio 2014
0

Oral anticoagulation – why do we need new drugs

Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis

16 Junho 2014
0